About Atropos Health
Atropos Health is a healthcare AI company that provides a physician consultation service powered by research-grade real-world evidence (RWE). The company’s platform, GENEVA OS™, transforms health data into usable real-world evidence, leveraging electronic medical record (EMR) data to derive digital evidence for individual patient outcomes. [1, 6, 17, 21] This approach aims to address the significant evidence gap in healthcare, where many clinical decisions and treatment guidelines lack sufficient clinical evidence, often forcing physicians to rely on underpowered trials or expert opinion. [5, 6, 22, 23]
Atropos Health’s technology allows for the rapid generation of observational studies and personalized evidence, reducing the time from months to minutes through tools like ChatRWD, a generative AI chatbot. [5, 15, 18] This enables clinicians and researchers to quickly access insights from clinical data, supporting data-driven care, expediting research, and improving individual patient outcomes. [17, 20, 24] The company’s mission is to democratize access to high-quality RWE, particularly for underserved, comorbid, and complex patients who are often excluded from traditional clinical trials. [3, 6, 7]
Focus Areas
Business Intelligence
| Key Investors | Valtruis, Cencora Ventures, McKesson Ventures, Merck Global Health Innovation Fund, Breyer Capital, Emerson Collective, Presidio Ventures, Boston Millennia Partners, Hanwha Asset Management (USA), Mana Ventures, Cerity Partners Ventures |
| Partnerships | Stanford Health Care, Mayo Clinic Platform, Janssen Research & Development, Arcadia, Databricks, Microsoft, Guidehouse, Ontada, Novartis, Meta, Heidi Health, Vim, Avo, Autonomize AI, Vye Health, Humata, Google Cloud Marketplace |
| Acquisitions | unknown |
| Technology | GENEVA OS™ (operating system for rapid healthcare evidence), ChatRWD™ (chat-based AI co-pilot), Atropos Evidence™ Agent, Forge™ (low-code RWE research platform), cloud-native, federated multi-nodal queries, TQL (temporal query language) |
What Physicians Need to Know
Atropos Health offers physicians access to personalized, on-demand real-world evidence to inform clinical decisions and answer specific patient questions that may not be addressed in traditional literature. Their tools, like the Atropos Evidenceu2122 Agent, integrate into existing EHR workflows, providing patient-specific insights without requiring physicians to leave their workflow. Physicians can utilize Atropos Health to evaluate medications for formulary consideration, improve patient care and safety, and even contribute to publication-grade studies. The platform aims to reduce guesswork and provide high-quality, trustworthy evidence, with a badge system indicating the reliability of AI-generated responses.
Atropos Health's technology, including GENEVA OSu00ae, is available on Google Cloud Marketplace, allowing healthcare and life science organizations to deploy their tools within their Google Cloud environment. They integrate with various platforms and partners, including Microsoft Dragon Copilot and Stanford Health Care's ChatEHR, to embed RWE into clinical workflows. They also partner with companies like Arcadia and Ontada to expand their evidence network and enhance data access for precision medicine and oncology. Additionally, they collaborate with physician workflow platforms such as Vim, Avo, Autonomize AI, and Vye Health, and prior authorization company Humata, to bring novel precision evidence into existing healthcare workflows.
Reviews & Opinions
Videos
News, demos, and interviews about Atropos Health.
Videos load interactively. If none appear, search YouTube for Atropos Health →
Press & Coverage
Frequently Asked Questions
Investors
Who's funded Atropos Health.
Related Companies
QuickIntell is an AI-first healthcare technology company dedicated to transforming healthcare operations for physicians and healthcare providers. The company leverages advanced AI agents, including Computer Vision, Machine Learning, Optical Character Recognition (OCR), and Natural Language Processing (NLP), to streamline administrative workflows and enhance Revenue Cycle Management (RCM). QuickIntell’s solutions are designed to reduce administrative burden, […]
Ease Tax Relief, founded in 2016, is a tax relief and resolution company based in Harleysville, PA. The company specializes in helping individuals and small businesses resolve issues with the IRS, offering services such as Offer in Compromise, Partial Pay Installment Agreements, Payment Plans, and Penalty Reduction. Owned and operated by Zheng Yang, a CPA […]
CAIMed, the Lower Saxony Center for Artificial Intelligence and Causal Methods in Medicine, is a research institution dedicated to advancing personalized healthcare through innovative AI and causal methodologies. The center aims to address widespread diseases such as cancer, cardiovascular diseases, and infections by linking research data, clinical data, and patient care data. This integrated approach, […]
Autoderm is a health technology company that provides a CE-marked AI dermatology screening API designed to analyze smartphone photos for various skin conditions. The company’s AI models are trained on a proprietary database of amateur smartphone images of skin diseases and are accessible via an API that can be integrated into various platforms, including electronic […]
OCTA is an AI-powered finance automation platform that aims to streamline financial operations and accelerate cash flow for businesses, particularly SMEs and enterprises in the Middle East, with a strong presence in the UAE and Saudi Arabia. The platform utilizes AI agents to automate tasks across the entire contract-to-cash cycle, including contract creation, e-signing, invoicing, […]
Skin Analytics is a British health technology company dedicated to the early and accurate diagnosis of skin cancer, aiming to reduce mortality from the disease. They achieve this through their flagship product, DERM, an AI-powered medical device. DERM is designed to provide dermatologist-quality skin cancer assessments, making them more accessible and reducing the burden on […]